University of Wisconsin Hospital & Clinics
Madison, Wisconsin, 53792, United States
NCT Number: NCT00585624
We are proposing to evaluate the benefit of preoperative nutritional support with Impact Advanced Recovery in the most vulnerable group of elective gastrointestinal surgery patients who may experience a complication, esophagus and pancreas resections, and hypothesize that oral supplementation with 3 servings (0.75 L) Impact Advanced Recovery will reduce postoperative stay by 10-20% and reduce the incidence of major complications by 25%.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Madison, Wisconsin, 53792, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nutritional supplement
No supplement
Time frame: Postoperative stay in hospital & 30 days
Time frame: Postoperative stay in hospital & 30 days
University of Wisconsin, Madison
Other
Preoperative Nutritional Support Reduces Postoperative Stay and Incidence of Complications in Patients Undergoing an Esophagectomy or Pancreaticoduodenectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00708513
Adenocarcinoma, Carcinoma
Louisville, Kentucky, United States
View Trial DetailsNCT00827931
Biliary Tract Surgical Procedures, Colectomy
Surat, Gujarat, India
View Trial DetailsNCT01169051
Digestive System Diseases, Digestive System Neoplasms
View Trial DetailsNCT07312526
Digestive System Diseases, Digestive System Neoplasms
Shanghai, China
View Trial Details